Ensysce Biosciences, Inc.
ENSCWN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 15, 2026
22wMarket Overview
Stock performance and key metrics
ENSCW News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PF614 capsule | Phase 3 | Postoperative Pain, Acute | - | - |
PF614 | Phase 2 | Acute Pain | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply